S3524

SENATE, No. 3524

STATE OF NEW JERSEY

220th LEGISLATURE

INTRODUCED JANUARY 30, 2023

 


 

Sponsored by:

Senator M. TERESA RUIZ

District 29 (Essex)

 

 

 

 

SYNOPSIS

Requires non-invasive prenatal testing for pregnant persons and health insurance coverage for non-invasive prenatal testing.

 

CURRENT VERSION OF TEXT

As introduced.


An Act concerning prenatal testing for pregnant persons and health benefits coverage for prenatal testing, and supplementing Titles 17, 26, 30, and 52 of the Revised Statutes and Title 17B of the New Jersey Statutes.

 

Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

1. A hospital service corporation which provides hospital or medical expense benefits under a contract that is delivered, issued, executed, or renewed in this State or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide benefits under the contract for expenses incurred in conducting a non-invasive prenatal test for a pregnant person. The methods of testing for which benefits shall be provided shall include the most reliable, medically recognized screening test available. The method and frequency of testing to be utilized shall be in accordance with the most recent published guidelines of the American College of Obstetricians and Gynecologists.

The benefits shall be provided to the same extent as for any other medical condition under the contract.

As used in this section, non-invasive prenatal test means a blood test performed beginning at ten weeks of pregnancy that is used to screen for Down syndrome and other chromosomal abnormalities.

This section shall apply to those hospital service corporation contracts in which the hospital service corporation has reserved the right to change the premium.

 

2. A medical service corporation which provides hospital or medical expense benefits under a contract that is delivered, issued, executed, or renewed in this State or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide benefits under the contract for expenses incurred in conducting a non-invasive prenatal test for a pregnant person. The methods of testing for which benefits shall be provided shall include the most reliable, medically recognized screening test available. The method and frequency of testing to be utilized shall be in accordance with the most recent published guidelines of the American College of Obstetricians and Gynecologists.

The benefits shall be provided to the same extent as for any other medical condition under the contract.

As used in this section, non-invasive prenatal test means a blood test performed beginning at ten weeks of pregnancy that is used to screen for Down syndrome and other chromosomal abnormalities.

This section shall apply to those medical service corporation contracts in which the medical service corporation has reserved the right to change the premium.

 

3. A health service corporation which provides hospital or medical expense benefits under a contract that is delivered, issued, executed, or renewed in this State or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide benefits under the contract for expenses incurred in conducting a non-invasive prenatal test for a pregnant person. The methods of testing for which benefits shall be provided shall include the most reliable, medically recognized screening test available. The method and frequency of testing to be utilized shall be in accordance with the most recent published guidelines of the American College of Obstetricians and Gynecologists.

The benefits shall be provided to the same extent as for any other medical condition under the contract.

As used in this section, non-invasive prenatal test means a blood test performed beginning at ten weeks of pregnancy that is used to screen for Down syndrome and other chromosomal abnormalities.

This section shall apply to those health service corporation contracts in which the health service corporation has reserved the right to change the premium.

 

4. An individual health insurer which provides hospital or medical expense benefits under a policy that is delivered, issued, executed, or renewed in this State or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide benefits under the contract for expenses incurred in conducting a non-invasive prenatal test for a pregnant person. The methods of testing for which benefits shall be provided shall include the most reliable, medically recognized screening test available. The method and frequency of testing to be utilized shall be in accordance with the most recent published guidelines of the American College of Obstetricians and Gynecologists.

The benefits shall be provided to the same extent as for any other medical condition under the contract.

As used in this section, non-invasive prenatal test means a blood test performed beginning at ten weeks of pregnancy that is used to screen for Down syndrome and other chromosomal abnormalities.

This section shall apply to those policies in which the insurer has reserved the right to change the premium.

5. A group health insurer which provides hospital or medical expense benefits under a policy that is delivered, issued, executed, or renewed in this State or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance, on or after the effective date of this act, shall provide benefits under the contract for expenses incurred in conducting a non-invasive prenatal test for a pregnant person. The methods of testing for which benefits shall be provided shall include the most reliable, medically recognized screening test available. The method and frequency of testing to be utilized shall be in accordance with the most recent published guidelines of the American College of Obstetricians and Gynecologists.

The benefits shall be provided to the same extent as for any other medical condition under the contract.

As used in this section, non-invasive prenatal test means a blood test performed beginning at ten weeks of pregnancy that is used to screen for Down syndrome and other chromosomal abnormalities.

This section shall apply to those policies in which the insurer has reserved the right to change the premium.

 

6. A certificate of authority to establish and operate a health maintenance organization in this State shall not be issued or continued on or after the effective date of this act by the Commissioner of Banking and Insurance unless the health maintenance organization provides health care services in conducting a non-invasive prenatal test for a pregnant person. The methods of testing for which benefits shall be provided shall include the most reliable, medically recognized screening test available. The method and frequency of testing to be utilized shall be in accordance with the most recent published guidelines of the American College of Obstetricians and Gynecologists.

The health care services shall be provided to the same extent as for any other medical condition under the contract.

As used in th